Thomas Milz
Corporate Officer/Principal en APONTIS PHARMA AG .
Cargos activos de Thomas Milz
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
APONTIS PHARMA AG | Corporate Officer/Principal | 01/01/2021 | - |
PP Apontis Pharma GmbH
PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019. | Director Ejecutivo | 01/05/2021 | - |
Historial de carrera de Thomas Milz
Antiguos cargos conocidos de Thomas Milz.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/2017 | 01/01/2018 |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/2007 | 01/01/2016 |
Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | 01/01/1997 | 01/01/1999 |
Ventas & Marketing | 01/01/1999 | 01/01/2007 | |
Sanol GmbH | Ventas & Marketing | 01/01/1999 | 01/01/2007 |
Madaus AG | Corporate Officer/Principal | 01/01/1996 | 01/01/1997 |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/1993 | 01/01/1996 |
Formación de Thomas Milz.
Fachhochschule Düsseldorf | Undergraduate Degree |
Estadísticas
Internacional
Alemania | 9 |
Operativa
Corporate Officer/Principal | 6 |
Sales & Marketing | 2 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APONTIS PHARMA AG | Health Technology |
Empresas privadas | 6 |
---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Schwarz Pharma Deutschland GmbH | |
PP Apontis Pharma GmbH
PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019. | Finance |
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
Sanol GmbH | |
Madaus AG |
- Bolsa de valores
- Insiders
- Thomas Milz
- Experiencia